Enanta Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $183k | 15k | 11.97 |
| 2025-06-30 | $363k | 48k | 7.56 |
| 2025-03-31 | $255k | 46k | 5.52 |
| 2024-12-31 | $179k | 31k | 5.75 |
| 2024-09-30 | $304k | 29k | 10.36 |
| 2024-06-30 | $126k | 9.7k | 12.97 |
| 2024-03-31 | $355k | 20k | 17.45 |
| 2023-12-31 | $200k | 21k | 9.42 |
| 2023-09-30 | $145k | 13k | 11.17 |
| 2023-06-30 | $931k | 44k | 21.40 |
| 2023-03-31 | $417k | 10k | 40.44 |
| 2022-12-31 | $1.8M | 38k | 46.52 |
| 2022-09-30 | $114k | 2.2k | 52.39 |
| 2022-06-30 | $563k | 12k | 46.23 |
| 2022-03-31 | $1.8M | 25k | 71.65 |
| 2021-12-31 | $3.0M | 40k | 74.68 |
| 2021-09-30 | $1.8M | 31k | 56.79 |
| 2021-06-30 | $485k | 11k | 44.03 |
| 2021-03-31 | $1.3M | 26k | 49.33 |
| 2020-12-31 | $4.0k | 94 | 42.55 |
| 2020-06-30 | $23k | 456 | 50.44 |
| 2020-03-31 | $252k | 4.9k | 51.35 |
| 2019-12-31 | $370k | 5.9k | 62.76 |
| 2019-09-30 | $1.7M | 28k | 60.07 |
| 2019-06-30 | $524k | 6.2k | 84.62 |
| 2019-03-31 | $14k | 128 | 111.11 |
| 2018-12-31 | $2.2M | 31k | 73.33 |
| 2018-09-30 | $1.1M | 12k | 85.65 |
| 2018-06-30 | $565k | 4.9k | 115.99 |
| 2018-03-31 | $2.2M | 28k | 80.86 |
| 2017-12-31 | $122k | 2.1k | 59.12 |
| 2017-09-30 | $349k | 7.4k | 46.86 |
| 2017-06-30 | $12k | 321 | 37.38 |
| 2017-03-31 | $8.0k | 271 | 29.52 |
| 2016-12-31 | $296k | 8.8k | 33.55 |
| 2016-09-30 | $71k | 2.7k | 26.90 |
| 2016-06-30 | $280k | 12k | 23.33 |
| 2016-03-31 | $30k | 989 | 30.00 |
| 2015-12-31 | $912k | 28k | 33.00 |
| 2015-09-30 | $258k | 7.1k | 36.17 |
| 2015-03-31 | $9.0k | 300 | 30.00 |